Pharmacogenomics of gemcitabine: can genetic studies lead to tailor-made therapy?

Por Ueno, H, Kiyosawa, K, Kaniwa, N
Publicado em 2007

Vertical Integration of Pharmacogenetics in Population PK/PD Modeling: A Novel Information Theoretic Method

Por Knights, J, Chanda, P, Sato, Y, Kaniwa, N, Saito, Y, Ueno, H, Zhang, A, Ramanathan, M
Publicado em 2013

Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients

Por Ueno, H, Kaniwa, N, Okusaka, T, Ikeda, M, Morizane, C, Kondo, S, Sugiyama, E, Kim, S R, Hasegawa, R, Saito, Y, Yoshida, T, Saijo, N, Sawada, J
Publicado em 2009